Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 281 of 6351
-
Gut bacteria boosts immunotherapy in kidney cancer trial
Disease control Recruiting nowThis phase II trial compares the effect of adding a Live Biotherapeutic Product called CBM588 to pembrolizumab versus pembrolizumab alone in preventing return of disease (recurrence) after surgery for patients with renal cell cancer. Pembrolizumab is an immune checkpoint inhibito…
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Personalized antibiotic strategy aims to prevent deadly infections after kidney transplant
Disease control Not yet recruitingKidney transplant recipients take medicines that suppress the immune system to prevent rejection of the transplanted kidney. As a result, they have a high risk of infections, especially urinary tract infections (UTIs). Some of these infections can spread to the bloodstream and ca…
Phase 3 • Sponsor: Susanne Dam Nielsen, MD, DMSc • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Could a new drug sharpen the minds of people with schizophrenia?
Symptom relief Not yet recruitingSchizophrenia is a long-lasting and serious mental health disorder that affects about 1% of people worldwide. It can cause symptoms such as hallucinations and delusions (called positive symptoms), confused or disorganized thinking, reduced motivation and emotional expression (neg…
Phase 3 • Sponsor: European Group for Research In Schizophrenia • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
New drug may help preemies breathe easier, avoid opioids
Symptom relief Not yet recruitingDespite the increasing use of non-invasive ventilation, a large majority of premature neonates still receive invasive ventilation during their NICU (neonatal intensive care unit) stay. Invasive ventilation is a unanimous source of discomfort and pain. As opposed to the adult and…
Phase 2/3 • Sponsor: Centre Hospitalier Intercommunal Creteil • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC
-
Magic mushroom therapy for depression? new trial tests psilocybin and CBT in groups
Symptom relief Not yet recruitingThis study will seek to determine the (1) acceptability and (2) feasibility of psilocybin as an adjunct to cognitive-behavioral therapy, delivered as a group treatment (G-PACBT) for major depressive disorder and (3) explore the clinical effects of G-PACBT on depressive symptoms a…
Phase 2 • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Fetal heart surgery could change life for babies with Half-Formed hearts
Disease control By invitation onlyThe purpose of this research is to investigate the best way to manage evolving hypoplastic left heart syndrome (HLHS).
Sponsor: Mauro H. Schenone • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
MRNA cancer shot shows promise in early trial
Disease control Not yet recruitingPMC2129G12 is an investigational intratumorally administered messenger RNA-lipid nanoparticle (mRNA-LNP) immunotherapy designed to enable localized, transient expression of a humanized EpCAM-targeted CD3-engaging bispecific antibody together with the immunostimulatory cytokines t…
Phase 1/2 • Sponsor: IntraAb, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Brain bleed breakthrough? new drug could stop fluid buildup without surgery
Disease control Not yet recruitingHydrocephalus is a serious condition in which fluid builds up inside the brain, often requiring lifelong surgical placement of a shunt to drain excess cerebrospinal fluid (CSF). One of the most common causes of hydrocephalus is bleeding into the brain's fluid spaces after aneurys…
Phase 1/2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Experimental interferon boosts hopes for rectal cancer remission
Disease control Not yet recruitingThis is a multi-center, randomized, phase II study, aimed to evaluate the efficacy of investigational product at a dose of 1800 µg/day when given in combination with TNT. There will be two arms included in this study: Arm A (TNT regimen \+ 1800 µg/day of rSIFN-co treatment) and …
Phase 2 • Sponsor: Sichuan Huiyang Life Science and Technology Corporation • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a One-Week shock wave treatment fix shoulder tears?
Disease control Not yet recruitingThis is a multicenter, randomized controlled clinical study exploring three different extracorporeal shock wave therapy (ESWT) regimens for patients with partial rotator cuff tears, a common cause of chronic shoulder pain and limited movement. Traditional ESWT uses a once-weekly …
Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New rapid tests aim to speed up ebola and lassa fever diagnosis
Diagnosis Not yet recruitingThis study aim to validate the clinical performances of two newly developed isothermal nucleic acid amplification bioassays modules for EBOV and LASV. Two retrospective studies will be conducted using biobanked patient samples such as plasma samples and buccal swabs already colle…
Sponsor: Institute of Tropical Medicine, Belgium • Aim: Diagnosis
Last updated Jul 04, 2026 00:00 UTC
-
New rapid ebola test could speed up outbreak detection
Diagnosis Not yet recruitingThis study aims to validate the clinical performance of a newly developed isothermal nucleic acid amplification bioassay module for EBOV. A retrospective studies will be conducted using biobanked patient samples such as plasma samples and buccal swabs already collected by the Ins…
Sponsor: Institute of Tropical Medicine, Belgium • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
Spinal fluid DNA test could personalize brain cancer therapy
Diagnosis Not yet recruitingThis prospective, single-center study will evaluate whether cerebrospinal fluid (CSF) circulating tumor DNA (ctDNA) testing using the Belay Summit assay can improve the clinical management of patients with malignant gliomas or brain metastases from non-small cell lung cancer (NSC…
Sponsor: Alireza Mansouri • Aim: Diagnosis
Last updated Jul 10, 2026 00:00 UTC
-
Can a memory drug break the grip of Anorexia's rigid habits?
Disease control Not yet recruitingThe purpose of this study is to test the feasibility and tolerability of donepezil in a small group of patients with anorexia nervosa (AN). Study participants will be receiving care at the New York State Psychiatric Institute Eating Disorders Unit. Study medication will be increa…
Phase 2 • Sponsor: New York State Psychiatric Institute • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a simple color change improve breathing support for preemies?
Disease control Not yet recruitingThe aim of NEU-CAP is to investigate the clinical impact of using a colorimetric carbon dioxide (CO₂) detector during non-invasive ventilation (NIV). Infants born before 32 weeks of gestation will be included in this trial. This is a stepped-wedge cluster randomised controlled tr…
Sponsor: Leiden University Medical Center • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Rapid test may cut time on wrong antibiotics after lung transplant
Diagnosis Not yet recruitingPostoperative pneumonia significantly worsens the prognosis for patients undergoing lung transplantation (LT). It is therefore recommended to use antibiotic prophylaxis after LT, although the specific types of antibiotics or the duration of treatment are not specified. Internatio…
Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Diagnosis
Last updated Aug 30, 2026 00:00 UTC
-
A Two-Pronged attack on sedentary aging: less sitting, more Nrf2
Disease control Not yet recruitingExercise is the cornerstone of rehabilitation and an essential part of treatment plans for many chronic conditions; however, our understanding of why certain individuals respond positively to exercise while others do not remains incomplete. Physical inactivity and sedentary behav…
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can coaching and walking ease pain in liver disease?
Symptom relief Not yet recruitingThe goal of this clinical trial is to test a low-touch vs high-touch drug-free pain self-management program that may help lower pain and improve quality of life for adults with cirrhosis and pain. Participants are assigned by chance to one of two study groups. The groups receive …
Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
Hidden heart vessel damage may explain type 2 heart attacks
Diagnosis Not yet recruitingThe purpose of this research is to find out if patients with Type 2 Myocardial Infarction (T2MI) without significant epicardial coronary artery disease (CAD) have a greater chance of having coronary microvascular disease (CMD).
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Sep 02, 2026 00:00 UTC
-
Can a Stomach-Derived peptide help tendons heal faster after surgery?
Disease control Not yet recruitingThis study is a randomized, double-blind, placebo-controlled pilot trial investigating the effects of BPC-157 on tendon healing and functional recovery following arthroscopic rotator cuff repair (aRCR). BPC-157 is a synthetic peptide that has demonstrated promising regenerative a…
Phase 1 • Sponsor: University of Arkansas • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC